RESUMO
This study proposes the beta-emitting radioisotope 143Pr as a promising candidate for palliative treatment of metastatic bone pain due to its desirable physical decay characteristics. An optimized process was developed for the production and purification of non-carrier-added 143Pr using a medium flux research reactor. Calculations were performed to determine the optimal irradiation time and cooling period for irradiating 1 mg of natural cerium oxide to indirectly produce 143Pr through the decay of 143Ce. Following irradiation and cooling, extraction chromatography was employed to efficiently isolate 143Pr from the irradiated target material. A column containing Ln-resin was used along with nitric acid as the mobile phase and an optional oxidation step with NaBrO3/ascorbic acid to separate 143Pr from impurities such as 143Ce and 141Ce. Radionuclidic purity of over 99.995% was achieved as confirmed through gamma spectroscopy, demonstrating effective separation of 143Pr. Additional quality control analyses established the chemical and radiochemical purity of the purified 143Pr nitrate product. With a half-life of 13.6 days and maximum beta energy of 0.937 MeV, 143Pr exhibits favorable properties for palliative bone pain therapy. This study therefore provides a viable method for producing high-purity 143Pr through the optimized irradiation and purification processes described. Further investigation is warranted to explore potential clinical applications of 143Pr for palliation of metastatic bone cancer pain.
Assuntos
Neoplasias Ósseas , Cuidados Paliativos , Neoplasias Ósseas/radioterapia , Neoplasias Ósseas/complicações , Cuidados Paliativos/métodos , Humanos , Dor do Câncer/tratamento farmacológico , Compostos Radiofarmacêuticos/uso terapêutico , Compostos Radiofarmacêuticos/química , Radioisótopos/uso terapêutico , Radioisótopos/isolamento & purificação , Radioisótopos/químicaRESUMO
Predicting source or background radionuclide emissions is limited by the effort needed to run gas/aerosol atmospheric transport models (ATMs). A high-performance surrogate model is developed for the HYSPLIT4 (NOAA) ATM to accelerate transport simulation through model reduction, code optimization, and improved scaling on high performance computing systems. The surrogate model parameters are a grid of short-duration transport simulations stored offline. The surrogate model then predicts the path of a plume of radionuclide particles emitted from a source, or the field of sources which may have contributed to a detected signal, more efficiently than direct simulation by HYSPLIT4. Termed the Atmospheric Transport Model Surrogate (ATaMS), this suite of capabilities forms a basis to accelerate workflows for probabilistic source prediction and estimation of the radionuclide atmospheric background.
Assuntos
Monitoramento de Radiação , Radioisótopos/isolamento & purificação , Aerossóis , Simulação por Computador , Estudos RetrospectivosRESUMO
OBJECTIVE: In the recent time, endoradionuclide therapy for metastatic castration-resistant prostate carcinoma employing 177Lu-PSMA-617 has yielded encouraging results and several clinical trials with the agent are currently ongoing. Routine preparation of 177Lu-PSMA-617 patient doses can be made simpler and convenient, if the ingredients essential for radiolabeling are made available in a ready-to-use lyophilized form. METHODS: PSMA-617 freeze-dried kit was formulated and used for the preparation of 177Lu-PSMA-617 clinical dose with high radiochemical purity using low/medium specific activity 177Lu. Detailed radiochemical studies were performed to determine the maximum activity and volume of 177LuCl3, which can be added in the kit for the formulation of 177Lu-PSMA-617. Studies were also performed to determine the shelf life of the kit to ensure its long-term usage. Studies were performed in buffer as well as human serum medium to determine the stability of the 177Lu-PSMA-617 complex after storing in respective media up to 7 days postpreparation. About ten patient doses of 177Lu-PSMA-617 were administered, and posttherapy scans were acquired. RESULTS: The formulated freeze-dried kit of PSMA-617 could be radiolabeled with an average percentage radiochemical purity > 98.53 ± 0.38. The freeze-dried kit was found suitable for tolerating up to 0.5 mL of 177LuCl3 (in 0.01 N HCl) and specific activity of 555 MBq/µg (15 mCi/µg) for the preparation of the patient dose of 177Lu-PSMA-617. The 177Lu-PSMA-617 complex prepared using the freeze-dried kit of PSMA-617 was observed to maintain % radiochemical purity (RCP) of 96.74 ± 0.87 and 94.81 ± 2.66, respectively, even after storing up to 7 days in buffer and human serum, respectively. 177Lu-PSMA-617 prepared using the in-house formulated freeze-dried kit of PSMA-617 exhibited accumulation in metastatic lesions picked up in a pretherapy PET scan. Reduction in number as well as size of lesions was observed in posttherapy scans acquired after two months of administering the first therapeutic dose of 177Lu-PSMA-617. CONCLUSIONS: The freeze-dried kit of PSMA-617 could be used for the preparation of 177Lu-PSMA-617 with high radiochemical purity (>98%) in a reproducible manner. 177Lu-PSMA-617 prepared using the developed kit was successfully evaluated in patients suffering from metastatic prostate cancer.
Assuntos
Dipeptídeos/isolamento & purificação , Dipeptídeos/uso terapêutico , Compostos Heterocíclicos com 1 Anel/isolamento & purificação , Compostos Heterocíclicos com 1 Anel/uso terapêutico , Lutécio/isolamento & purificação , Lutécio/uso terapêutico , Antígeno Prostático Específico/isolamento & purificação , Antígeno Prostático Específico/uso terapêutico , Neoplasias da Próstata/radioterapia , Radioisótopos/isolamento & purificação , Radioisótopos/uso terapêutico , Compostos Radiofarmacêuticos/isolamento & purificação , Compostos Radiofarmacêuticos/uso terapêutico , Animais , Dipeptídeos/farmacocinética , Composição de Medicamentos/métodos , Estabilidade de Medicamentos , Liofilização , Compostos Heterocíclicos com 1 Anel/farmacocinética , Humanos , Técnicas In Vitro , Lutécio/farmacocinética , Masculino , Farmácia Nuclear/métodos , Serviço de Farmácia Hospitalar , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Antígeno Prostático Específico/farmacocinética , Neoplasias da Próstata/diagnóstico por imagem , Neoplasias da Próstata/patologia , Neoplasias de Próstata Resistentes à Castração/diagnóstico por imagem , Neoplasias de Próstata Resistentes à Castração/patologia , Neoplasias de Próstata Resistentes à Castração/radioterapia , Radioquímica/métodos , Radioquímica/normas , Radioisótopos/farmacocinética , Compostos Radiofarmacêuticos/farmacocinética , Ratos , Ratos Wistar , Distribuição TecidualRESUMO
Accelerator-based techniques with electromagnetic mass separation are considered among the most innovative and promising strategies to produce non-conventional radionuclides for nuclear medicine. Such approach was successfully used at CERN, where the dedicated MEDICIS facility was built, and at TRIUMF, where the ISAC radioactive beam facility was used to produce unconventional α-emitters. In such framework, the Legnaro National Laboratories of the Italian Institute of Nuclear Physics (INFN-LNL) proposed the ISOLPHARM project (ISOL technique for radioPHARMaceuticals), which will exploit radionuclides producible with the SPES (Selective Production of Exotic Species) ISOL (Isotope Separation On-Line) facility to develop novel radiopharmaceuticals. The ISOL technique utilizes the irradiation with a primary beam of particles/nuclei of a production target where radionuclides are produced. A radioactive ion beam is subsequently extracted from the production target unit, and transported up to an analyzing magnet, where non-isobaric contaminants are filtered out. The so-obtained purified radioactive beam is dumped onto an implantation substrate, referred as collection target. Then, the desired nuclides can be chemically harvested from the collected isobars, and the isotopically pure atom collection can be employed to radiolabel high specific activity radiopharmaceuticals. Metallic deposition targets in the form of coated metal foils were mostly used at TRIUMF and CERN. At ISOLPHARM, a different approach is under investigation which foresees the use of soluble cold-pressed collection targets, possibly facilitating the chemical purification process of the collected radionuclides. In this study, the production and characterization of some of the ISOLPHARM collection targets is presented, in particular, soluble salts (NaCl and NaNO3) and organic materials widely used for pharmaceutical tablets production are considered. All such materials proved to be potentially suitable as collection targets, since solid samples were easily produced and resulted compatible with the vacuum conditions required for the ion implantation process. Furthermore, some of the selected substrates were used for proof-of-concept deposition tests with stable silver, to prove their suitability as ISOLPHARM deposition substrates for silver-111, a promising candidate for radiotherapy. Such tests highlighted possible scenarios useful for the development of new alternative materials, as the use of insoluble organic targets.
Assuntos
Radioisótopos/química , Medicina Nuclear/métodos , Radioisótopos/isolamento & purificação , CintilografiaRESUMO
Decontamination of unprotected skin areas is crucial to prevent excessive penetration of chemical contaminants after criminal or accidental release. A review of literature studies was performed to identify the available decontamination methods adopted to treat skin contamination after chemical, radiological and metal exposures. In this bibliographic review, an overview of the old and recent works on decontamination procedures followed in case of potential hazards substances contaminations with a comparison between these systems are provided. Almost all data from our 95 selected studies conducted in vitro and in vivo revealed that a rapid skin decontamination process is the most efficient way to reduce the risk of intoxication. The commonly-used or recommended conventional procedures are simple rinsing with water only or soapy water. However, this approach has some limitations because an easy removal by flushing may not be sufficient to decontaminate all chemical deposited on the skin, and skin absorption can be enhanced by the wash-in effect. Other liquid solutions or systems as adsorbent powders, mobilizing agents, chelation therapy are also applied as decontaminants, but till nowadays does not exist a decontamination method which can be adopted in all situations. Therefore, there is an urgent need to develop more efficient and successful decontaminating formulations.
Assuntos
Descontaminação/métodos , Substâncias Perigosas/isolamento & purificação , Pele/efeitos dos fármacos , Substâncias para a Guerra Química/isolamento & purificação , Humanos , Nanopartículas Metálicas/química , Metais/isolamento & purificação , Radioisótopos/isolamento & purificação , Absorção Cutânea , Sabões/química , Água/químicaRESUMO
NOVELTY STATEMENT: Ecologically suitable methods for the decontamination of liquid radioactive waste or radioactively contaminated areas are becoming more and more important due to the pollution of the planet. We believe that phytoremediation of radionuclides using microalgae is one of the optimal ecological methods to decontamination of radioactive waste. Microalgae as unicellular organisms have a number of advantages over the other organisms used in bioremediation-high level of tolerance to the environment, fast growth rates, high tolerance to various pH levels, etc. In this study, we used 3 different strains of microalgae for phytoremediation of various radionuclides (137Cs, 60Co, 241Am, and 239Pu). This research was focused on ex situ phytoremediation of radionuclides using microalgae at various pH levels of radioactively contaminated solutions. Due to the ability of microalgae to adapt to sometimes even extreme pH values, this research may be interesting for many institutions and researchers dealing with more environmentally friendly methods of decontamination of radioactive waste.
Assuntos
Biodegradação Ambiental , Chlamydomonas reinhardtii , Chlorella vulgaris , Radioisótopos/isolamento & purificação , Scenedesmus , Poluentes Radioativos da Água/isolamento & purificação , MicroalgasRESUMO
The application of diagnostic and therapeutic radionuclides in nuclear medicine has grown significantly and has translated into the increased interest in radionuclide generators and their development. 224Ra and its shorter-lived daughters, 212Pb and 212Bi, are very interesting radionuclides from Targeted Alpha Therapy point of view for treatment of small cancers or metastatic forms. The purpose of the present work was to develop a simple generator for rapid elution of carrier-free 224Ra from 232U or 228Th sources by radiochemical separation based on extraction chromatography with the utilization of a home-made material. The bis(2-ethylhexyl) hydrogen phosphate (HDEHP) extractant was immobilized on polytetrafluroethylene (PTFE) grains and its ability to selectively adsorb 232U and 228Th, with simultaneous high elution recovery of 224Ra, was checked over few years. The 224Ra was quantitatively eluted with small volume (3-5 mL) of 0.1 M HNO3 with low breakthrough (<0.005%) and was used for further milking of 212Bi and 212Pb from DOWEX 50WX12 by 0.75 M and 2.0 M HCl, respectively. The elaborated here methods allowed high recovery of 224Ra, 212Pb and 212Bi radionuclides and their application in radiolabeling of various biomolecules.
Assuntos
Bismuto/isolamento & purificação , Radioisótopos de Chumbo/isolamento & purificação , Radioisótopos/isolamento & purificação , Rádio (Elemento)/isolamento & purificação , Tório/isolamento & purificação , Cromatografia/métodos , Radioisótopos/químicaRESUMO
Designing skin decontaminating materials with outstanding therapeutic effects, adhesiveness, and suitable mechanical property has great practical significance in radionuclide-contaminated skin wound healing. Here, a physically crosslinked hydrogel is constructed via hydrogen bonding of poly acrylamide, sodium alginate (SA), and the complexing agent diethylene triamine pentaacetic acid (DTPA). The physical and chemical properties of the poly(AAm-SA-DTPA) hydrogel (PASD) are detected according to established methods. The decontaminating property and skin wound healing of the PASD are investigated to confirm multi-functions of wound dressing. The physical and chemical properties results show that the synthesis of the PASD hydrogel is effective and that DTPA is present in the hydrogel. The hydrogel also shows great mechanical and swelling properties. In vitro tests find that PASD shows significant scavenging abilities for strontium and cerium. In vivo experiments show that the PASD hydrogel can remove radioactive strontium from the skin wounds of mice, and can effectively prevent the absorption of radioactive strontium through the skin wound. Furthermore, the PASD hydrogel can effectively promote the formation of granulation tissue in a radioactive contaminated wound. Taken together, the PASD hydrogels, which has good mechanical properties and radionuclides decontamination, is expected to be used as a dressing for radionuclide-contaminated skin wound healing.
Assuntos
Descontaminação/métodos , Hidrogéis , Radioisótopos/isolamento & purificação , Pele/lesões , Ferimentos e Lesões , Resinas Acrílicas/química , Alginatos/química , Animais , Animais não Endogâmicos , Ligação de Hidrogênio , Camundongos , Estresse Oxidativo , Ácido Pentético/análise , Pele/metabolismo , Espectroscopia de Infravermelho com Transformada de Fourier , Fator de Crescimento Transformador beta1/metabolismo , Cicatrização , Ferimentos e Lesões/metabolismoRESUMO
Production of medical radionuclides with ISOL facilities is a unique production method that may provide access to preclinical quantities of some rare and potent radionuclides for nuclear medicine. Particularly attention over the past years was focused on several promising candidates for Targeted Radionuclides Therapy (TRT). With this review, we provide some perspectives of using the TRIUMF ISOL facility (ISAC) to produce medical radionuclides for TRT application and highlight our current effort to collect of 165Er and 155Tb for Auger Therapy and SPECT imaging, respectively.
Assuntos
Radioquímica/instrumentação , Radioisótopos/química , Radioisótopos/isolamento & purificaçãoRESUMO
Theranostic strategies involve select radionuclides that allow diagnostic imaging and tailored radionuclide therapy in the same patient. An example of a Food and Drug Administration-approved theranostic pair is the 68Ga- and 177Lu-labeled DOTATATE peptides, which are used to image neuroendocrine tumors, predict treatment response, and treat disease. However, when using radionuclides of 2 different elements, differences in the pharmacokinetic and pharmacodynamic profile of the agent can occur. Theranostic agents that incorporate the matched-pair radionuclides of scandium-43Sc/47Sc or 44Sc/47Sc-would guarantee identical chemistries and pharmacologic profiles. The aim of this study was to investigate production of 43,44,47Sc via proton-induced nuclear reactions on titanium nuclei using a 24-MeV cyclotron. Methods: Aluminum, niobium, and tantalum target holders were used with titanium foils and pressed TiO2 to produce scandium radionuclides with proton energies of up to 24 MeV. Irradiated targets were digested using NH4HF2 and HCl in a closed perfluoroalkoxy alkane vessel in 90 min. Scandium radionuclides were purified via ion-exchange chromatography using branched N,N,N',N'-tetra-2-ethylhexyldiglycolamide. The titanium target material was recovered via alkali precipitation with ammonia solution. Results: Titanium foil and TiO2 were digested with an average efficiency of 98% ± 3% and 95% ± 1%, respectively. The typical digestion time was 45 min for titanium foil and 75 min for TiO2 The average scandium recovery was 94% ± 3%, and the average titanium recoveries from digested titanium foil and TiO2 after precipitation as TiO2 were 108% ± 8% and 104% ± 5% of initial mass, respectively. Conclusion: This work demonstrated a robust method for the cyclotron production of scandium radionuclides that could be used with natural or enriched TiO2 target material.
Assuntos
Ciclotrons , Radioquímica/instrumentação , Radioisótopos/química , Escândio/química , Titânio/química , Transporte Biológico , Linhagem Celular Tumoral , Dipeptídeos/química , Dipeptídeos/metabolismo , Compostos Heterocíclicos com 1 Anel/química , Compostos Heterocíclicos com 1 Anel/metabolismo , Humanos , Antígeno Prostático Específico , Radioisótopos/isolamento & purificação , Escândio/isolamento & purificaçãoRESUMO
Copper oxide nanoparticles (CuO NPs) are needed in various fields, especially in the biomedical field. CuO NPs was obtained from Aspergillus terreus filtrate. CuO NPs structure was confirmed by UV-Vis spectrophotometry, as well as Fourier transform infrared (FT-IR), X-ray diffraction (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). XRD offers the nanoparticles purity of CuO biosynthesis. CuO NPs are spherical when examined with TEM. The average size of CuO NPs from TEM was 15.75 ± 3.95 nm. New composite of P (AA-AN)-NPs CuO was synthesized by biotechnology and the induced γ-radiation. The distribution coefficient value (Kd) of 47Sc(III) as well as 47Ca(II) ions for the synthetic new composite was determined by batch technique. Radiochemical separation of 47Sc(III) from irradiated calcium target was studied using chromatographic column packed with the new composite material. The recovery yield of 78 ± 1.2% for 47Sc(III) was obtained using 1 M HCl. The quality control tests (chemical, radionuclide and radiochemical purities) of the eluted 47Sc confirmed that it's adequate for nuclear medicine applications.
Assuntos
Cobre/metabolismo , Nanopartículas Metálicas/química , Radioisótopos/isolamento & purificação , Escândio/isolamento & purificação , Aspergillus/metabolismo , Cobre/efeitos da radiação , Humanos , Nanopartículas Metálicas/efeitos da radiação , Nanopartículas Metálicas/ultraestrutura , Nanocompostos/química , Nanocompostos/efeitos da radiação , Nanocompostos/ultraestrutura , Medicina Nuclear , Tamanho da Partícula , Controle de Qualidade , Radioquímica , Radioisótopos/normas , Compostos Radiofarmacêuticos/isolamento & purificação , Compostos Radiofarmacêuticos/normas , Escândio/normas , Nanomedicina Teranóstica/métodosRESUMO
A simple and efficient separation method of carrier-free 47Sc from neutron irradiated titanium target using a novel chitosan-acrylic acid/multiwalled carbon nanotubes (CS-AA/MWCNTs) composite was established. The synthesis of the CS-AA/MWCNTs composite was achieved using gamma radiation-induced template polymerization. The grafting efficiency (GE%) of AA on CS onto the surface of f-MWCNTs reached a maximum of~84% under the optimized conditions (30 wt% CS, 1.0 wt% AA, 0.15 wt% f-MWCNTs, >0.2 wt% N,N'-Methylenebisacrylamide (NMBA), and irradiation dose ~25 kGy). Different analyses (FT-IR, SEM, TGA and DTA) were examined for confirming the structural morphology and mechanical properties of the new synthesized composite. Interestingly, the CS-AA/MWCNTs composite depicted a selective adsorption of Sc(III) rather than Ti(IV) ions at pH 5 with adsorption efficiency of ~93.93%. The ionic exchange separation of no-carrier-added (NCA)47Sc(III) from irradiated TiO2 target on CS-AA/MWCNTs composite packed column efficiently eluted 47Sc(III) by 91 ± 0.8% using 1 M HCl solution. The quality control tests (radionuclidic, radiochemical, and chemical purities) for the eluted 47Sc(III) clarified its high purity and validity for cancer theranostics.
Assuntos
Acrilatos/química , Quitosana/química , Resinas Compostas/síntese química , Nanotubos de Carbono/química , Nêutrons , Radioisótopos/isolamento & purificação , Escândio/isolamento & purificação , Titânio/química , Adsorção , Cromatografia Líquida , Resinas Compostas/química , Análise Diferencial Térmica , Concentração de Íons de Hidrogênio , Microscopia Eletrônica de Varredura , Nanotubos de Carbono/ultraestrutura , Polimerização , Medicina de Precisão , Radioisótopos/análise , Radioisótopos/química , Escândio/análise , Escândio/química , Espectroscopia de Infravermelho com Transformada de Fourier , Propriedades de Superfície , Termogravimetria , Titânio/efeitos da radiaçãoRESUMO
Silver-111 (111Ag, t1/2 = 7.47 d) is a ß- emitter suitable for targeted cancer therapy due to favourable decay properties. The production of no-carrier added 111Ag via Isotope Separation On-Line (ISOL) technique is being investigated at the Legnaro National Laboratories of the Italian Institute of Nuclear Physics (ISOLPHARM project). Stable Cadmium-111 (111Cd) is co-produced as isobaric contaminant, hence a chemical separation process must be developed to selectively harvest 111Ag. In this study, a chromatographic procedure employing the commercially available CL resin was investigated by using stable Ag+ and Cd2+. Results indicate that CL resin allows to efficiently separate Ag+ from Cd2+ and recover the former with high yields.
Assuntos
Radioisótopos/isolamento & purificação , Prata/isolamento & purificação , Extração em Fase Sólida/métodos , Estudo de Prova de ConceitoRESUMO
The increased interest in 89Zr-labelled immunoPET imaging probes for use in preclinical and clinical studies has led to a rising demand for the isotope. The highly penetrating 511 and 909 keV photons emitted by 89Zr deliver an undesirably high radiation dose, which makes it difficult to produce large amounts manually. Additionally, there is a growing demand for Good Manufacturing Practices (GMP)-grade radionuclides for clinical applications. In this study, we have adopted the commercially available TRASIS mini AllinOne (miniAiO) automated synthesis unit to achieve efficient and reproducible batches of 89Zr. This automated module is used for the target dissolution and separation of 89Zr from the yttrium target material. The 89Zr is eluted with a very small volume of oxalic acid (1.5 mL) directly over the sterile filter into the final vial. Using this sophisticated automated purification method, we obtained satisfactory amount of 89Zr in high radionuclidic and radiochemical purities in excess of 99.99%. The specific activity of three production batches were calculated and was found to be in the range of 1351-2323 MBq/µmol. ICP-MS analysis of final solutions showed impurity levels always below 1 ppm.
Assuntos
Radioisótopos/química , Radioisótopos/metabolismo , Compostos Radiofarmacêuticos/química , Compostos Radiofarmacêuticos/metabolismo , Zircônio/química , Zircônio/metabolismo , Humanos , Tomografia por Emissão de Pósitrons , Radioisótopos/isolamento & purificação , Compostos Radiofarmacêuticos/isolamento & purificação , Zircônio/isolamento & purificaçãoRESUMO
Most of South Africa's energy is derived from the combustion of coal in pulverized coal-fired power plants (CFPP). However, when compared with the rest of the world, limited information regarding the main radioactive elements (U and Th) and specific radionuclides of interest (K40, Ra226 and Th232) from South African CFPP is available in the public domain. This paper aims to quantify the U, Th and specific radionuclides found in the coal used in selected South African CFPP in comparison to world averages found in literature. The U and Th concentrations were obtained by ICP-MS. The main radionuclides, K40, Ra226 and Th238, were quantified using gamma spectrometry. The U concentration and Th concentrations for the coal used in all the power plants was above the world average of 1.9 mg/kg and 3.2 mg/kg respectively. The coals with the highest Th content originated from the Mpumalanga power plant, while the U content in the Freestate power plant samples was the highest of the three. The concentrations of the K40 were between 88.43±10.75-110.76±8.92 Bq/kg, which are in-line with world averages of 4-785 Bq/kg. Similarly, the Ra226 and Th232 values were between 21.69±2.83-52.63±4.04 Bq/kg and 19.91±1.24-22.97±1.75 Bq/kg respectively, which are also in line with the world averages of 1-206 Bq/kg and 1-170 Bq/kg respectively. Radiological hazard indices such as radium equivalent (Raeq); external hazard index (Hex) and internal hazard index (Hin), that were estimated from these average radionuclide concentrations were less than the prescribed values found in literature. This indicated that no significant health risk was posed by the coal being used from these coal fields.
Assuntos
Carvão Mineral/análise , Centrais Elétricas , Poluentes Radioativos do Solo/isolamento & purificação , Cinza de Carvão/análise , Humanos , Doses de Radiação , Monitoramento de Radiação , Radioisótopos/química , Radioisótopos/isolamento & purificação , Rádio (Elemento)/química , Rádio (Elemento)/isolamento & purificação , Poluentes Radioativos do Solo/química , África do Sul , Espectrometria gama , Tório/química , Tório/isolamento & purificação , Urânio/química , Urânio/isolamento & purificaçãoRESUMO
BACKGROUND: 44Sc is becoming attractive as a PET radionuclide due to its decay characteristics. It can be produced from 44Ca present in natural calcium with 2.08% abundance. MATERIALS AND METHODS: The targets were mostly prepared from natural CaCO3 or metallic calcium in the form of pellets. After irradiation they were dissolved in 3 M hydrochloric acid and 44Sc was separated from excess of calcium by precipitation of scandium hydroxide using ammonia. Alternatively, targets were dissolved in 11 M hydrochloric acid and 44Sc was separated by extraction chromatography on UTEVA resin. As the next step, in both processes 44Sc was further purified on a cation exchange resin. Initially, the separation procedures were developed with 46Sc as a tracer. Gamma spectrometry with a high purity germanium detector was used to determine the separation efficiency. Finally, the CaCO3 pellet with 99.2% enrichment in 44Ca was activated with protons via 44Ca(p,n)44Sc nuclear reaction. RESULTS: Altogether twenty two irradiations and separations were performed. The working procedures were developed and the quality of separated 44Sc solution was confirmed by radiolabeling of DOTATATE. The chemical purity of the product was sufficient for preclinical experiments. At the end of around 1 hour proton beam irradiation of CaCO3 pellet with 99.2% enrichment in 44Ca the obtained radioactivity of 44Sc was more than 4.8 GBq. CONCLUSION: 44Sc can be produced inexpensively with adequate yields and radionuclidic purity via 44Ca(p,n)44Sc nuclear reaction in small cyclotrons. The recovery yield in both investigated separation methods was comparable and amounted above 90%. The obtained 44Sc was pure in terms of radionuclide and chemical purity, as shown by the results of peptide radiolabeling.
Assuntos
Elementos da Série Actinoide/química , Precipitação Química , Hidróxidos/química , Radioquímica/métodos , Radioisótopos/química , Radioisótopos/isolamento & purificação , Escândio/química , Escândio/isolamento & purificação , Urânio/química , Carbonato de Cálcio/química , Ciclotrons , Marcação por Isótopo , Radioquímica/instrumentaçãoRESUMO
The adsorption of lithium ions(Li+) and the separation of lithium isotopes have attracted interests due to their important role in energy storage and nuclear energy, respectively. However, it is still challenging to separate the Li+ and its isotopes with high efficiency and selectivity. A novel cellulose-based microsphere containing crown ethers groups (named as MCM-g-AB15C5) was successfully synthesized by pre-irradiation-induced emulsion grafting of glycidyl methacrylate (GMA) and followed by the chemical reaction between the epoxy group of grafted polymer and 4'-aminobenzo-15-crown-5 (AB15C5). By using MCM-g-AB15C5 as adsorbent, the effects of solvent, metal ions, and adsorption temperature on the adsorption uptake of Li+ and separation factor of 6Li/7Li were investigated in detail. Solvent with low polarity, high adsorption temperature in acetonitrile could improve the uptake of Li+ and separation factor of lithium isotopes. The MCM-g-AB15C5 exhibited the strongest adsorption affinity to Li+ with a separation factor of 1.022 ± 0.002 for 6Li/7Li in acetonitrile. The adsorption isotherms in acetonitrile is fitted well with the Langmuir model with an ultrahigh adsorption capacity up to 12.9 mg·g-1, indicating the unexpected complexation ratio of 1:2 between MCM-g-AB15C5 and Li+. The thermodynamics study confirmed the adsorption process is the endothermic, spontaneous, and chemisorption adsorption. As-prepared novel cellulose-based adsorbents are promising materials for the efficient and selective separation of Li+ and its isotopes.
Assuntos
Celulose/química , Éteres de Coroa/química , Lítio/isolamento & purificação , Radioisótopos/isolamento & purificação , Acetonitrilas/química , Adsorção , Eletricidade , Compostos de Epóxi/química , Metacrilatos/química , Microesferas , Energia Nuclear , TermodinâmicaRESUMO
The reliable and efficient production of radioisotopes for diagnosis and therapy is becoming an increasingly important capability, due to their demonstrated utility in Nuclear Medicine applications. Starting from the first processes involving the separation of 99mTc from irradiated materials, several methods and concepts have been developed to selectively extract the radioisotopes of interest. Even though the initial methods were based on liquid-liquid extraction (LLE) approaches, the perceived difficulty in automating such processes has slowly moved the focus towards resin separation methods, whose basic chemical principles are often similar to the LLE ones in terms of chelators and phases. However, the emerging field of flow chemistry allows LLE to be easily automated and operated in a continuous manner, resulting in an even improved efficiency and reliability. In this contribution, we will outline the fundamentals of LLE processes and their translation into flow-based apparatuses; in addition, we will provide examples of radioisotope separations that have been achieved using LLE methods. This article is intended to offer insights about the future potential of LLE to purify medically relevant radioisotopes.
Assuntos
Extração Líquido-Líquido , Radioisótopos/isolamento & purificação , Extração Líquido-Líquido/instrumentação , Extração Líquido-Líquido/métodos , Medicina Nuclear/instrumentação , Medicina Nuclear/métodosRESUMO
43,44Sc/47Sc is one of the most promising theranostic pairs in nuclear medicine. The co-emission of 1157â¯keV γ-rays with 99.9% branching ratio by 44Sc and the presence of its metastable state 44 mSc push to favour the adoption of 43Sc for Positron Emission Tomography (PET) diagnostic procedures to lighten the dose to the patient and to the personnel. The ß+ emitter 43Sc can be produced at a medical cyclotron by proton bombardment of an enriched 43Ca or 46Ti oxide target. 43Sc can be also produced by deuteron bombardment of an enriched 42Ca oxide target. Only a few medical cyclotrons currently in operation offer deuteron beams. Some can be adapted to operate both a proton or a deuteron source. To compare these three production routes, an accurate knowledge of the cross-sections is essential. In this paper, we report on the cross-section measurement of the reaction 42Ca(d,n)43Sc performed at the 6 MV HVEC EN-Tandem of the Ion Beam Physics group at ETH in Zürich. A study of the production yield by using commercially available enriched target materials is also presented.
Assuntos
Marcação por Isótopo/métodos , Radioisótopos/isolamento & purificação , Escândio/isolamento & purificação , Radioisótopos de Cálcio/química , Ciclotrons , Deutério , Humanos , Tomografia por Emissão de Pósitrons , Prótons , Compostos Radiofarmacêuticos/isolamento & purificação , Nanomedicina TeranósticaRESUMO
Rhenium therapeutic radioisotopes, namely rhenium-186 and 188, are radionuclides that have been used in combination with various ligands to provide different radiopharmaceuticals for the treatment of different diseases for many years. Each of these radioisotopes has its own special attributes, which make it appropriate to destroy special-sized tumors. High energy, long range beta particles in 188Re can give this certainty that large tumors can be eradicated with high efficiency. On the other hand, 186Re with low energy, short range beta particles is adequate item to ruin small tumors with minimum side effects and high yield. Thus, each of these radioisotopes has features that can cover just part of the treatment individually. So we thought accompanying 186Re and 188Re must have the best outcome to treat tumors with various sizes. Irradiating natural rhenium with neutrons has this potential to produce parallel 186Re and 188R together. We are looking for investigating whether the natural rhenium irradiation, in addition the concurrent production of these radioisotopes, gives us the appropriate radioactivity values to produce compositional radiopharmaceuticals? In this research, the experimental and theoretical assessments of 186Re and 188R simultaneous production to reach compositional radiopharmaceutical by natural rhenium irradiation in the Tehran research reactor, as well as the type and amount of produced impurities have been investigated. The results showed that experimental data are in good agreement with theoretical calculations. The maximum relative error in data has been calculated 8%. The results showed that, in the simultaneous production 186Re and 188R via the natural rhenium irradiation method, the amounts of impurities are trivial compared to the main products, and the activities of main products are properly enough to produce compositional radiopharmaceuticals.